Track Progenity's long-term debt ($14M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2024), PROG shows a long-term debt of $14M. That compares with $81M in the prior-year period — down 82.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PROG's long-term debt is now $14M (was $81M) — a 82.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Progenity is outperforming or lagging.
Tracking PROG's long-term debt over time shows whether Progenity is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $81M in the prior-year period — down 82.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Progenity's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $14M) with ownership activity and broader fundamentals.
Progenity's long-term debt is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.